Disease

Recent Scholarly Publications

Records 16 / 16

Healthy Aging in Asia

May 2020

Life expectancy in Japan, South Korea, and much of urban China has now outpaced that of the United States and other high-income countries.

Smoking, Life Expectancy, and Chronic Disease in South Korea, Singapore, and the United States: A Microsimulation Model

November 2019

The substantial social and economic burden attributable to smoking is well‐known, with heavy smokers at higher risk of chronic disease and premature mortality than light smokers and nonsmokers.

Economic Impact of Diabetes in South Asia: the Magnitude of the Problem

May 2019

With an estimated 84 million people suffering from diabetes in South Asia, the disease imposes substantial economic burdens on individuals, families, and society.

Will Demographic Change Slow China's Rise?

June 2013

China's population of 1.34 billion is now 50 percent urban, over 13 percent above age 60, and with 118 boys born for every 100 girls.

Prevention of Chronic Noncommunicable Disease in Mongolia: A Facility-Based Qualitative Study

October 2012

Nutrition, physical activity, smoking, and alcohol consumption are major causes of morbidity and mortality related to noncommunicable diseases (NCDs).

The Quality of Life and Mortality risk of Elderly People in Rural China: The Role of Family Support

June 2012

The elderly share of China’s population is projected to grow well beyond the capacity of the nation’s social security system.

Emerging Infectious Disease Surveillance in Southeast Asia: Cambodia, Indonesia, and the Naval Area Medical Research Unit 2

January 2012

Emerging infectious diseases (EIDs) pose international security threats because of their potential to inflict harm upon humans, crops, livestock, health infrastructure, and economies.

Socioeconomic Correlates of Inpatient Spending for Patients with Type 2 Diabetes Mellitus in China: Evidence from Hangzhou

January 2012

Aims: We evaluated the factors associated with inpatient costs including total costs, pharmaceutical costs and laboratory costs for diabetes-related admissions.

Quality Adjustment for Health Care Spending on Chronic Disease: Evidence from Diabetes Treatment, 1999-2009

May 2011

Although U.S. health care expenditures reached 17.6 percent of GDP in 2009, quality measurement in this important service sector remains limited.

Recalibration of the Framingham Equations in the Thai Population

April 2011

We derived equations for predicting cardiovascular disease (CVD) risks for Thai men and women, separately, over a specific time period using associations between risk factors and CVD events from...

Prevention and Control of Chronic Non-communicable Disease in Nine Pacific Rim Cities

December 2010

Populous, economically dynamic, and rapidly urbanizing, the Asia Pacific both reflects and strongly shapes trends in global public health.

The Global Challenge of Antimicrobial Resistance: Insights from Economic Analysis

August 2010

The prevalence of antimicrobial resistance (AR) limits the therapeutic options for treatment of infections, and increases the social benefit from disease prevention.

The Net Value of Health Care for Patients With Type 2 Diabetes, 1997 to 2005

December 2009

Background.  The net value of increased health care spending remains unclear, especially for chronic diseases. Objective.

Pandemic Influenza and the Globalization of Public Health

December 2009

When one can circle the globe in less than the time of incubation of most infectious pathogens, it is clear every country relies to some extent on the health systems of other countries to prevent...

Does Your Health Care Depend on How Your Insurer Pays Providers? Variation in Utilization and Outcomes in Thailand

March 2009

Hospitals in Thailand operate in a multiple insurance payment environment.